1. Agarwal M, Thomas K, Peter JV, Jeyaseelan L, Cherian AM (1998) A randomized double-blind sham-controlled study of intrathecal human anti-tetanus immunoglobulin in the management of tetanus. Natl Med J India 11: 209–912
2. Alejandria MM, Lansang MA, Dans LF, Mantaring JB (2002) Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev: CD001090
3. Andresen I, Kovarik JM, Spycher M, Bolli R (2000) Product equivalence study comparing the tolerability, pharmacokinetics, and pharmacodynamics of various human immunoglobulin-G formulations. J Clin Pharmacol 40: 722–730
4. Anonymous (1999) Report of an IUIS Scientific Committee: Primary Immunodeficiency Diseases. Clin exp Immunol 118 (Suppl): 1–28
5. Anonymous (2001) Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten, Bundesaerztekammer edn. Deutscher Aerzte-Verlag, Köln